Correction to: The modifying effect of mutant LRRK2 on mutant GBA1-associated Parkinson disease
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Glycation End Products research · Parkinson's Disease Mechanisms and Treatments · Nuclear Receptors and Signaling
This is a correction to: Vera Serebryany-Piavsky, Lian Egulsky, Julia Elia Manoim-Wolkovitz, Saar Anis, Sharon Hassin-Baer, Moshe Parnas, Mia Horowitz, The modifying effect of mutant LRRK2 on mutant GBA1-associated Parkinson disease, Human Molecular Genetics, 2025, ddaf062, https://doi.org/10.1093/hmg/ddaf062
In the originally published version of this manuscript, the authors' first and last names were erroneously transposed.
This has been corrected.